Aging mitochondria and inflammation

Mitochondrial Aging Promotes Inflammation

NIH-funded research Merrimack College · NIH-11123529

A mitochondria-targeted approach is being tested to lower age-related inflammation that can worsen Alzheimer's and other age-related conditions in older adults.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionMerrimack College NIH-funded
Lab location1 site (North Andover, United States)
Project IDNIH-11123529 on NIH RePORTER

What this research studies

This project looks at how mitochondria in immune cells change with age and drive inflammatory signals linked to Alzheimer's. Researchers focus on STAT3 moving into mitochondria (mitoSTAT3), which alters mitochondrial structure, complex II (succinate dehydrogenase) activity, and the energy use of aging T cells. They reduce mitoSTAT3 using a mitochondria-targeted inhibitor (Mtcur-1) and genetic methods, then measure mitochondrial function and Th17-related cytokines (IL-17A/F, IL-21, IL-6, TNFα). Experiments use aged immune cells and disease-relevant models to see whether lowering mitoSTAT3 cuts proinflammatory signals tied to age-related diseases.

Who could benefit from this research

Good fit: The work is most relevant to older adults and people with early or established Alzheimer's or other age-related inflammatory conditions who might donate samples or later join related clinical trials.

Not a fit: Younger people without age-related inflammation or those whose cognitive problems are driven by non-inflammatory causes are unlikely to benefit directly from this project.

Why it matters

Potential benefit: If successful, this work could point to new treatments that reduce harmful age-related inflammation and potentially slow or lessen Alzheimer's-related damage.

How similar studies have performed: Preclinical studies have shown mitoSTAT3 can change mitochondrial function and that mitochondria-targeted inhibitors like Mtcur-1 lower Th17 inflammation, but translation to patients has not yet been proven.

Where this research is happening

North Andover, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.